Browsing Centre for Cancer Biomarkers & Biotherapeutics by Author "ATOMIC-Meso Study Group"
Now showing items 1-1 of 1
-
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical Trial.
Szlosarek, PW; Creelan, BC; Sarkodie, T; Nolan, L; Taylor, P; Olevsky, O; Grosso, F; Cortinovis, D; Chitnis, M; Roy, A (American Medical Association, 2024-02-15)IMPORTANCE: Arginine deprivation using ADI-PEG20 (pegargiminase) combined with chemotherapy is untested in a randomized study among patients with cancer. ATOMIC-Meso (ADI-PEG20 Targeting of Malignancies Induces ...